Oramed Pharmaceuticals (ORMP) Interest & Investment Income (2012 - 2026)
Oramed Pharmaceuticals (ORMP) posted Interest & Investment Income of $276000.0 for Q1 2026, down 57.34% on a QoQ basis from $647000.0 in Q1 2025, and down 57.34% year-over-year from $647000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Interest & Investment Income (2012 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $276000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 57.34% year-over-year to $276000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 2.42% YoY) and the FY2025 annual result came in at $2.4 million, down 52.38% from the prior year.
- Interest & Investment Income was $276000.0 for Q1 2026 at Oramed Pharmaceuticals, down from $647000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.5 million in Q2 2023 and bottomed at $158000.0 in Q4 2022.
- A 4-year average of $864285.7 and a median of $544000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 608.0% — and 2026, when it tumbled 57.34%.
- Oramed Pharmaceuticals' Interest & Investment Income stood at $158000.0 in 2022, then soared by 1468.35% to $2.5 million in 2023, then plunged by 73.89% to $647000.0 in 2025, then sank by 57.34% to $276000.0 in 2026.
- Business Quant data shows ORMP's Interest & Investment Income at $276000.0 in Q1 2026, $647000.0 in Q1 2025, and $2.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Oramed Pharmaceuticals | 169.21 Mn | 169.21 Mn | - | 276,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276,000.00 |
| Mar 31, 2025 | 647,000.00 |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 158,000.00 |
| Jun 30, 2022 | 350,000.00 |
| Mar 31, 2022 | 544,000.00 |
| Aug 31, 2021 | 1.24 Mn |
| Nov 30, 2012 | 118,521.00 |